Journal
CURRENT OPINION IN PHARMACOLOGY
Volume 8, Issue 4, Pages 427-432Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.coph.2008.06.012
Keywords
-
Categories
Ask authors/readers for more resources
Over the past few years small molecule inhibitors of both Src family kinases and focal adhesion kinase (FAK) have entered clinical studies for the treatment of solid tumours. These adhesion-linked kinases are involved in a number of pathways that have impact on the behaviour of tumour cells and the challenge is now, how to take these forward in the clinical setting.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available